High-parameter immune monitoring panel

Dr. Hurley will provide an overview of psychosocial challenges faced by patients deciding to undergo genetic testing. Her presentation will combine research findings from psychosocial research and case illustrations from twenty years of providing psychotherapy to genetic counseling patients. She will provide tips on communication strategies as well as common pitfalls to avoid, and discuss advantages of creating an “information plan” based on patients’ needs, preferences, and ability to absorb emotionally challenging information. Clinical examples will be drawn from Dr. Hurley’s specialty in hereditary cancer risk, with the discussion of how psychosocial issues in genetic testing are relevant across a broad range of conditions, from the prenatal setting to other pediatric- and adult-onset hereditary syndromes.

As gene-modified cell therapies advance to address new indications, the need for rapid development of robust manufacturing processes becomes increasingly important.

Biocompatibility is a critical part of the regulatory approval process for most medical devices. Scientific understanding of biological risks and the tools available to assess them are evolving.

Upgrading the CRISPR Toolbox - New Strategies Sharpen the CRISPR-Cas9 Scissors Utilizing Visualization and Chromatic Accessibility